← Back to Search

Respiratory Muscle Training for Breast Cancer

N/A

Recruiting

Led By Tracey L O'Connor

Research Sponsored by Roswell Park Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cognitively capable of following direction and performing the intervention

Age >= 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline, 6 weeks, and 12 weeks

Awards & highlights

Study Summary

This trial tests if home-based breathing exercises can help reduce side effects in breast cancer patients.

Who is the study for?

This trial is for adults over 18 with breast cancer who are about to start or are currently receiving chemotherapy. Participants must be able to understand English, follow instructions, and have signed a consent form. It's not suitable for those with severe illnesses like heart failure, active infections, or mental health conditions that could affect participation.Check my eligibility

What is being tested?

The study tests if doing respiratory muscle training at home can reduce side effects from breast cancer treatment. This involves breathing exercises aimed at strengthening lung function and may be easier than aerobic exercise during treatment.See study design

What are the potential side effects?

Respiratory muscle training is generally safe but might include discomfort from the exercises or fatigue. Since it's non-invasive, serious side effects are unlikely compared to drug treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can understand and follow instructions.

Select...

I am 18 years old or older.

Select...

I have breast cancer and am scheduled for additional treatment before or after surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, 6 weeks, and 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, 6 weeks, and 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 6 weeks, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of patients who participate in the study

Proportion of patients who perform > 70% of their RMT sessions

Proportion of patients who perform >= 3 respiratory muscle training (RMT) sessions/week

+1 more

Secondary outcome measures

Anxiety

Assess Dyspnea

Assess Fatigue

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group II (Moderate to highter resistance RMT)Experimental Treatment3 Interventions

Patients undergo RMT using a respiratory muscle training device with moderate to higher breathing resistance for 12 weeks on study.

Group II: Group I (low resistance RMT Group)Active Control4 Interventions

Patients receive usual care for 12 weeks on study and a Respiratory Muscle training Device with small breathing resistance

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Respiratory Muscle Training

2013

N/A

~140

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor

402 Previous Clinical Trials

30,977 Total Patients Enrolled

10 Trials studying Breast Cancer

1,638 Patients Enrolled for Breast Cancer

Tracey L O'ConnorPrincipal InvestigatorRoswell Park Cancer Institute

1 Previous Clinical Trials

83 Total Patients Enrolled

Shipra Gandhi, MDPrincipal InvestigatorRoswell Park Cancer Institute

2 Previous Clinical Trials

55 Total Patients Enrolled

Media Library

Respiratory Muscle Training Clinical Trial Eligibility Overview. Trial Name: NCT05787834 — N/A

Breast Cancer Research Study Groups: Group I (low resistance RMT Group), Group II (Moderate to highter resistance RMT)

Breast Cancer Clinical Trial 2023: Respiratory Muscle Training Highlights & Side Effects. Trial Name: NCT05787834 — N/A

Respiratory Muscle Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05787834 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies in this scientific experiment for patients to participate?

"Indeed, clinicaltrials.gov does not list this trial as being currently open for enrollment; it was initially posted on April 1st 2023 and last revised on March 14th 2023. Despite that, there are 2327 other studies actively recruiting right now."

Answered by AI

What is the desired outcome of this clinical research?

"The primary goal of this 12-week trial is to ascertain the proportion of patients who remain on study. Additional objectives include assessing lower body strength using the Short Physical Performance Battery, measuring dyspnea using the Dyspnea-12 questionnaire, and determining fatigue levels through use of the Brief Fatigue Inventory."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer

2023. "Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05787834.